Loading the security overview…
Where the tokens are
| Quarter | Reported | EPS | EPS vs year ago | Revenue | Revenue vs year ago | Consensus EPS |
|---|---|---|---|---|---|---|
| Q2 FY26ended Jul 4, 2026 | Jul 30, 2026 | $2.41 | +2912.5% | $1.72B | +16.4% | $1.40 |
| Q1 FY26ended Apr 4, 2026 | Apr 30, 2026 | $0.83 | — | $1.55B | +12.3% | $0.55 |
| Q4 FY25ended Jan 3, 2026 | — | $0.37 | −43.9% | $1.71B | +20.6% | — |
| Q3 FY25ended Sep 27, 2025 | — | $0.12 | +9.1% | $1.56B | +10.0% | — |
| Q2 FY25ended Jun 28, 2025 | — | $0.08 | −83.7% | $1.48B | +1.8% | — |
| Q1 FY25ended Mar 29, 2025 | — | −$0.16 | −132.0% | $1.38B | −2.8% | — |
| Q4 FY24ended Dec 28, 2024 | — | $0.66 | +26.9% | $1.42B | −12.2% | — |
| Q3 FY24ended Sep 28, 2024 | — | $0.11 | −85.7% | $1.42B | −12.5% |
Growth compares each quarter with the same fiscal quarter a year earlier, and is left blank where that quarter is missing or its figure was zero or a loss. Consensus is the estimate published before each report. It usually refers to adjusted EPS, so it is shown beside the GAAP figure rather than subtracted from it: the difference would not be a beat or a miss.
Figures describe Darling Ingredients shares, not any token. As of Jul 30, 2026, from Massive's standardised financials and the earnings calendar.
| — |
| Q2 FY24ended Jun 29, 2024 | — | $0.49 | — | $1.46B | — | — |
| Q1 FY24ended Mar 30, 2024 | — | $0.50 | — | $1.42B | — | — |
| Q4 FY23ended Dec 30, 2023 | — | $0.52 | — | $1.61B | — | — |
| Q3 FY23ended Sep 30, 2023 | — | $0.77 | — | $1.63B | — | — |